Hopitaux Universitaires Pitie Salpetriere

The medical center is at the forefront of research in intensive care, particularly focusing on the optimization of regional citrate anticoagulation during continuous extra-renal purification. This involves enhancing the effectiveness of anticoagulation by adjusting ionized serum calcium targets post-filter.

• Regional Citrate Anticoagulation
• Ionized calcium Targeting
• Continuous Extra-Renal Purification

These advancements aim to improve patient outcomes in critical care settings by refining anticoagulation protocols.

Specializing in anti-MAG neuropathy, the center is pioneering treatments using rituximab to enhance neurological function. This research is crucial for patients with autoimmune neuropathies, aiming to improve their quality of life through targeted therapies.

• Rituximab Therapy
• Neurological Disability Improvement
• Autoimmune Neuropathy

The center's work is instrumental in developing effective treatments for complex neurological conditions.

Focusing on glioblastoma, the center is exploring innovative treatments that combine metformin with radiotherapy and temozolomide. This approach targets oxidative phosphorylation in malignant gliomas, aiming to extend progression-free survival in patients.

• Glioblastoma Treatment
• Metformin and Radiotherapy
• Oxidative Phosphorylation Targeting

These efforts are paving the way for more effective cancer therapies by integrating metabolic interventions.

The center is advancing research in cerebral adrenoleukodystrophy (cALD) by evaluating the efficacy of leriglitazone. This work is crucial for increasing survival rates and improving the quality of life for patients with this rare genetic disorder.

• Leriglitazone Efficacy
• Survival Improvement
• Rare Genetic Disorders

By focusing on innovative treatments, the center is making significant strides in the management of rare diseases.

Research at the center includes evaluating cenerimod for systemic lupus erythematosus, aiming to reduce disease activity. This work is vital for developing new therapeutic strategies for autoimmune conditions.

• Systemic Lupus Erythematosus
• Cenerimod Effectiveness
• Autoimmune Disease Management

The center's research contributes to the understanding and treatment of complex autoimmune diseases.

Specializing in HIV research, the center is investigating the use of broadly neutralizing antibodies in combination with antiretroviral therapy. This approach aims to achieve HIV remission and improve long-term patient outcomes.

• HIV Remission Strategies
• Broadly Neutralizing Antibodies
• Antiretroviral Therapy

These studies are crucial for advancing HIV treatment and achieving sustained viral suppression.

The center is leading research in indolent systemic mastocytosis (ISM) by assessing the long-term safety and efficacy of avapritinib. This work is essential for improving the management of mast cell disorders.

• Avapritinib Efficacy
• Mast Cell Disorder Management
• Long-term Safety Assessment

Through innovative research, the center is enhancing treatment options for patients with mastocytosis.

Focusing on giant cell arteritis, the center is exploring the effects of tocilizumab discontinuation strategies. This research aims to optimize treatment protocols and improve patient outcomes in inflammatory vascular diseases.

• Tocilizumab Discontinuation
• Inflammatory Vascular Diseases
• Relapse-Free Survival

The center's work is pivotal in refining therapeutic approaches for complex vascular conditions.

Research at the center includes evaluating the combination of zibotentan and dapagliflozin for liver cirrhosis with portal hypertension. This study aims to improve hemodynamic parameters and patient outcomes.

• Liver Cirrhosis Management
• Zibotentan and dapagliflozin
• Portal Hypertension

These efforts are crucial for advancing treatment strategies in chronic liver diseases.

The center is pioneering research in pulmonary sarcoidosis by assessing the efficacy of OATD-01. This work focuses on reducing granulomatous inflammation and improving respiratory function.

• Pulmonary Sarcoidosis Treatment
• OATD-01 Efficacy
• Inflammation Reduction

Through innovative therapies, the center is enhancing the management of chronic respiratory conditions.